1. Home
  2. PIII vs OMIC Comparison

PIII vs OMIC Comparison

Compare PIII & OMIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PIII
  • OMIC
  • Stock Information
  • Founded
  • PIII 2015
  • OMIC 2016
  • Country
  • PIII United States
  • OMIC United States
  • Employees
  • PIII N/A
  • OMIC N/A
  • Industry
  • PIII Medical/Nursing Services
  • OMIC Medical/Dental Instruments
  • Sector
  • PIII Health Care
  • OMIC Health Care
  • Exchange
  • PIII Nasdaq
  • OMIC Nasdaq
  • Market Cap
  • PIII 32.2M
  • OMIC 34.9M
  • IPO Year
  • PIII N/A
  • OMIC 2021
  • Fundamental
  • Price
  • PIII $0.20
  • OMIC $19.40
  • Analyst Decision
  • PIII Buy
  • OMIC Hold
  • Analyst Count
  • PIII 3
  • OMIC 2
  • Target Price
  • PIII $2.38
  • OMIC $10.75
  • AVG Volume (30 Days)
  • PIII 336.1K
  • OMIC 19.3K
  • Earning Date
  • PIII 11-12-2024
  • OMIC 11-12-2024
  • Dividend Yield
  • PIII N/A
  • OMIC N/A
  • EPS Growth
  • PIII N/A
  • OMIC N/A
  • EPS
  • PIII N/A
  • OMIC N/A
  • Revenue
  • PIII $1,476,630,000.00
  • OMIC $2,667,000.00
  • Revenue This Year
  • PIII $21.45
  • OMIC $3.98
  • Revenue Next Year
  • PIII N/A
  • OMIC $242.05
  • P/E Ratio
  • PIII N/A
  • OMIC N/A
  • Revenue Growth
  • PIII 25.38
  • OMIC 2.77
  • 52 Week Low
  • PIII $0.18
  • OMIC $5.34
  • 52 Week High
  • PIII $1.78
  • OMIC $23.41
  • Technical
  • Relative Strength Index (RSI)
  • PIII 40.98
  • OMIC 47.01
  • Support Level
  • PIII $0.18
  • OMIC $19.00
  • Resistance Level
  • PIII $0.23
  • OMIC $20.55
  • Average True Range (ATR)
  • PIII 0.02
  • OMIC 0.80
  • MACD
  • PIII 0.00
  • OMIC -0.21
  • Stochastic Oscillator
  • PIII 38.24
  • OMIC 21.72

About PIII P3 Health Partners Inc.

P3 Health Partners Inc is a patient-centered and physician-led population health management company. P3's model aggregates and supports the community's existing healthcare resources to build a network of community providers working together to deliver coordinated and integrated care to patients with a shared commitment to improving patient outcomes, lowering cost, and delivering experience for all.

About OMIC Singular Genomics Systems Inc.

Singular Genomics Systems Inc is a life science technology company that is leveraging novel next generation sequencing and multiomics technologies to build products that empower researchers and clinicians. The product development pipeline comprises two initial integrated solutions, each designed to leverage Sequencing Engine and purpose built to address different applications. The G4 Sequencing Platform is designed to target the NGS market. The PX Integrated Solution is designed to target the single cell, spatial analysis and proteomics markets. Both integrated solutions are used in many different and diverse market segments, including basic biology, oncology, immunology, neurology, genetic diseases, infectious diseases, the human microbiome and many others.

Share on Social Networks: